Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y1UL
|
||||
Former ID |
DNC010328
|
||||
Drug Name |
(E)-3-(4-hydroxybenzylidene)indolin-2-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530673] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H11NO2
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)C(=CC3=CC=C(C=C3)O)C(=O)N2
|
||||
InChI |
1S/C15H11NO2/c17-11-7-5-10(6-8-11)9-13-12-3-1-2-4-14(12)16-15(13)18/h1-9,17H,(H,16,18)/b13-9+
|
||||
InChIKey |
PLAOAGFXNCEZMZ-UKTHLTGXSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Proto-oncogene tyrosine-protein kinase receptor ret | Target Info | Inhibitor | [530673] | |
WikiPathways | SIDS Susceptibility Pathways | ||||
Dopaminergic Neurogenesis | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.